Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk

被引:50
作者
Jorstad, Harald T. [1 ]
Colkesen, Ersen B. [1 ]
Boekholdt, S. Matthijs [1 ]
Tijssen, Jan G. [1 ]
Wareham, Nicholas J. [2 ]
Khaw, Kay-Tee [3 ]
Peters, Ron J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands
[2] Addenbrookes Hosp, Epidemiol Unit, MRC, Inst Metab Sci, Cambridge, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge, England
基金
英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; PRIMARY PREVENTION; EPIC-NORFOLK; PRIMARY-CARE; GUIDELINES; SURVIVAL; ASPIRIN; HEALTH; TRENDS; SCORE;
D O I
10.1136/heartjnl-2015-307668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The European Society of Cardiology's prevention guideline suggests that the risk of total (fatal plus non-fatal) cardiovascular disease (CVD) may be calculated from the risk of CVD mortality using a fixed multiplier (3x). However, the proposed multiplier has not been validated. We investigated the ratio of total CVD to CVD mortality in a large population-based cohort. Methods CVD mortality and total CVD (fatal plus non-fatal CVD requiring hospitalisation) were analysed using Kaplan-Meier estimates among 24014 men and women aged 39-79 years without baseline CVD or diabetes mellitus in the prospective population-based European Prospective Investigation of Cancer and Nutrition-Norfolk cohort. CVD outcomes included death and hospitalisations for ischaemic heart disease, heart failure, cerebrovascular disease, peripheral artery disease or aortic aneurysm. The main study outcome was the ratio of 10-year total CVD to 10-year CVD mortality stratified by age and sex. Results Ten year CVD mortality was 3.9% (900 CVD deaths, 95% CI 3.6% to 4.1%); the rate of total CVD outcomes was 21.2% (4978 fatal or non-fatal CVD outcomes, 95% CI 20.7% to 21.8%). The overall ratio of total CVD to CVD mortality was 5.4. However, we found major differences in this ratio when stratified by gender and age. In young women (39-50years), the ratio of total CVD to CVD mortality was 28.5, in young men (39-50years) 11.7. In the oldest age group, these ratios were considerably lower (3.2 in women and 2.4 in men aged 75-79years). Conclusions The relationship between 10-year total CVD and CVD mortality is dependent on age and sex, and cannot be estimated using a fixed multiplier. Using CVD mortality to estimate total CVD risk leads to serious underestimation of risk, particularly in younger age groups, and particularly in women.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 24 条
[1]  
[Anonymous], 2011, WHO I Global atlas on cardiovascular disease prevention and control
[2]  
[Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI [DOI 10.1056/NEJM198907203210301, 10.1056/NEJM198907203210301.]
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]  
Bennett N., 1995, HLTH SURV ENGL
[5]   Lifetime Risks of Cardiovascular Disease [J].
Berry, Jarett D. ;
Dyer, Alan ;
Cai, Xuan ;
Garside, Daniel B. ;
Ning, Hongyan ;
Thomas, Avis ;
Greenland, Philip ;
Van Horn, Linda ;
Tracy, Russell P. ;
Lloyd-Jones, Donald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :321-329
[6]   Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk prospective population study [J].
Boekholdt, MS ;
Peters, RJG ;
Day, NE ;
Luben, R ;
Bingham, SA ;
Wareham, NJ ;
Hack, CE ;
Reitsma, PH ;
Khaw, KT .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (06) :390-397
[7]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[8]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[9]   Cardiovascular Risk-Estimation Systems in Primary Prevention Do They Differ? Do They Make a Difference? Can We See the Future? [J].
Cooney, Marie Therese ;
Dudina, Alexandra ;
D'Agostino, Ralph ;
Graham, Ian M. .
CIRCULATION, 2010, 122 (03) :300-310
[10]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753